Bora CDMO Bora CDMO

X

Find the latest Drugs in Development and Pipeline Prospector News of Vaderis Therapeutics.

  • Webinars & Exhibitions

PharmaCompass
Send me more info on How To Grow My Bussiness Digitally?
Vaderis Therapeutics
Switzerland Flag
Country
Country
Switzerland
Address
Address
WSJ-350 3.05, Lichtstrasse 35, 4056 Basel
Telephone
Telephone
+41 79 592 20 05
Linkedin
Linkedin
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Details:

VAD044 is a once daily, orally administered, allosteric AKT inhibitor which has the potential to treat the underlying cause of Hereditary Haemorrhagic Telangiectasia (HHT), also known as Osler-Weber-Rendu Syndrome.


Lead Product(s): VAD044 L-Tartrate

Therapeutic Area: Genetic Disease Product Name: VAD044

Highest Development Status: Phase IProduct Type: Small molecule

Partner/Sponsor/Collaborator: Medicxi

Deal Size: Not Applicable Upfront Cash: Not Applicable

Deal Type: Not Applicable August 22, 2022

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY